Molecular Evolution
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Translation Readthrough Mitigation Joshua A
LETTER doi:10.1038/nature18308 Translation readthrough mitigation Joshua A. Arribere1, Elif S. Cenik1, Nimit Jain2, Gaelen T. Hess3, Cameron H. Lee3, Michael C. Bassik3 & Andrew Z. Fire1,3 A fraction of ribosomes engaged in translation will fail to into the 3′ UTR can confer substantial loss of protein expression for at terminate when reaching a stop codon, yielding nascent proteins least these three 3′ UTRs in C. elegans. inappropriately extended on their C termini. Although such To test whether translation into 3′ UTRs could confer a loss of extended proteins can interfere with normal cellular processes, protein expression more generally, a two-fluorescent-reporter system known mechanisms of translational surveillance1 are insufficient to with each fluorophore transgene containing an identical 3′ UTR was protect cells from potential dominant consequences. Here, through used. Nine genes were chosen to reflect a variety of functions and a combination of transgenics and CRISPR–Cas9 gene editing in expression levels: rps-17 (small ribosomal subunit component), r74.6 Caenorhabditis elegans, we demonstrate a consistent ability of cells (dom34/pelota release factor homologue), hlh-1 (muscle transcription to block accumulation of C-terminal-extended proteins that result factor), eef-1A.1 (also known as eft-3, translation elongation factor), from failure to terminate at stop codons. Sequences encoded by myo-2 (a pharyngeal myosin), mut-16 (involved in gene/transposon the 3′ untranslated region (UTR) were sufficient to lower protein silencing), bar-1 (a beta catenin), daf-6 (involved in amphid mor- levels. Measurements of mRNA levels and translation suggested a phogenesis), and alr-1 (neuronal transcription factor). -
2021 International Conference on Intelligent Biology and Medicine (ICIBM 2021)
2021 International Conference on Intelligent Biology and Medicine (ICIBM 2021) August 08-10, 2021 Virtual via Zoom Hosted by: The International Association for Intelligent Biology and Medicine (IAIBM), Temple University, The Perelman School of Medicine, University of Pennsylvania, and The University of Texas Health Science Center at Houston 1 TABLE OF CONTENTS Welcome .……………………………….…………………………... 4 Acknowledgments ……………………………….…………………. 5 Schedule ……………………………….………………………….... 9 Keynote speakers’ information ……………………………….….. 24 Eminent Scholar Talks ………….……………………………….. 32 Workshop and tutorial information …………………………… 40 Session information ……………………………….……………… 46 Poster session abstracts ……………………………….…………… 107 About IAIBM ……………………………………………….……. 136 Special Acknowledgements……...……………….………………… 137 2 Sponsorships……………………………………………………… 138 3 Welcome to ICIBM 2021! On behalf of all our conference committees and organizers, we welcome you to the 2021 International Conference on Intelligent Biology and Medicine (ICIBM 2021), co-hosted by The International Association for Intelligent Biology and Medicine (IAIBM), Temple University, and the Perelman School of Medicine at the University of Pennsylvania. Given the rapid innovations in the fields of bioinformatics, systems biology, and intelligent computing and their importance to scientific research and medical advancements, we are pleased to once again provide a forum that fosters interdisciplinary discussions, educational opportunities, and collaborative efforts among these ever growing and progressing fields. We are proud to have built on the successes of previous years’ conferences to take ICIBM 2021 to the next level. This year, our keynote speakers include Drs. James S. Duncan, Chunhua Weng, Ben Raphael, and Ying Xu. We also have four eminent scholar speakers from Drs. Yue Feng, Graciela Gonzalez-Hernandez, Kai Tan, and Wei Chen. These researchers are world-renowned experts in their respective fields, and we are privileged to host their talks at ICIBM 2021. -
Next Generation Exome Sequencing of Paediatric Inflammatory Bowel
Inflammatory bowel disease ORIGINAL ARTICLE Next generation exome sequencing of paediatric Gut: first published as 10.1136/gutjnl-2011-301833 on 28 April 2012. Downloaded from inflammatory bowel disease patients identifies rare and novel variants in candidate genes Katja Christodoulou,1 Anthony E Wiskin,2 Jane Gibson,1 William Tapper,1 Claire Willis,2 Nadeem A Afzal,3 Rosanna Upstill-Goddard,1 John W Holloway,4 Michael A Simpson,5 R Mark Beattie,3 Andrew Collins,1 Sarah Ennis1 < Additional materials are ABSTRACT published online only. To view Background Multiple genes have been implicated by Significance of this study these files please visit the association studies in altering inflammatory bowel journal online (http://dx.doi.org/ 10.1136/gutjnl-2011-301833). disease (IBD) predisposition. Paediatric patients often What is already known on this subject? manifest more extensive disease and a particularly < For numbered affiliations see Genome-wide association studies have impli- end of article. severe disease course. It is likely that genetic cated numerous candidate genes for inflamma- predisposition plays a more substantial role in this group. tory bowel disease (IBD), but evidence of Correspondence to Objective To identify the spectrum of rare and novel causality for specific variants is largely absent. Dr Sarah Ennis, Genetic variation in known IBD susceptibility genes using exome Furthermore, by design, genome-wide associa- Epidemiology and Genomic sequencing analysis in eight individual cases of childhood Informatics Group, Human tion studies are limited to the study of Genetics, Faculty of Medicine, onset severe disease. common variants and overlook the functionally University of Southampton, Design DNA samples from the eight patients underwent detrimental variation imposed by rare/novel Duthie Building (Mailpoint 808), targeted exome capture and sequencing. -
Non-Synonymous to Synonymous Substitutions Suggest That Orthologs Tend to Keep Their Functions, While Paralogs Are a Source of Functional Novelty
bioRxiv preprint doi: https://doi.org/10.1101/354704; this version posted July 23, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. Non-synonymous to synonymous substitutions suggest that orthologs tend to keep their functions, while paralogs are a source of functional novelty Mario Esposito1, Gabriel Moreno-Hagelsieb1,* 1 Dept of Biology, Wilfrid Laurier University, Waterloo, Ontario, Canada N2L 3C5 * [email protected] Abstract Because orthologs diverge after speciation events, and paralogs after gene duplication, it is expected that orthologs should tend to keep their functions, while paralogs have been proposed as a source of new functions. This does not mean that paralogs should diverge much more than orthologs, but it certainly means that, if there is a difference, then orthologs should be more functionally stable. Since protein functional divergence follows from non-synonymous substitutions, here we present an analysis based on the ratio of non-synonymous to synonymous substitutions (dN=dS). The results showed orthologs to have noticeable and statistically significant lower values of dN=dS than paralogs, not only confirming that orthologs keep their functions better, butalso suggesting that paralogs are a readily source of functional novelty. Author summary Homologs are characters diverging from a common ancestor, with orthologs being homologs diverging after a speciation event, and paralogs diverging after a duplication event. Given those definitions, orthologs are expected to preserve their ancestral function, while paralogs have been proposed as potential sources of functional novelty. -
Abstracts for the ??Evolutionary Medicine Conference
Ashdin Publishing Journal of Evolutionary Medicine ASHDIN Vol. 3 (2015), Article ID 235924, 45 pages publishing doi:10.4303/jem/235924 Abstracts CONFERENCE PROCEEDINGS Abstracts for the “Evolutionary Medicine Conference: Interdisciplinary Perspectives on Human Health and Disease” at the University of Zurich, Switzerland (July 30–August 1, 2015) Kaspar Staub,1 Nicole Bender,2 Paul Ewald,3 and Frank Ruhli¨ 1 1Institute of Evolutionary Medicine, University of Zurich, Winterthurerstrasse 190, CH-8057 Zurich, Switzerland 2Institute of Social and Preventive Medicine, University of Bern, Finkenhubelweg 11, CH-3012 Bern, Switzerland 3Department of Biology, University of Louisville, Louisville, KY 40292, USA Address correspondence to Frank Ruhli,¨ [email protected] Received 17 Aril 2015; Revised 11 May 2015; Accepted 14 May 2015 Copyright © 2015 Kaspar Staub et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Summary In summer 2015, the “Evolutionary Medicine Conference diseases. The discipline is now at a turning point at which a 2015: Interdisciplinary Perspectives on Human Health and Disease” rigorous application of evolutionary insights to the medical takes place at the Institute of Evolutionary Medicine, University of sciences will require not only assessing the validity of the Zurich, Switzerland. This international conference is the first of its kind in Europe and brings together eight distinguished keynote speak- full spectrum of possible explanations for each disease ers from all over the world as well as experts from different disci- but the interplay of different contributors to illness within plines (including medicine, anthropology, molecular/evolutionary biol- and between the three broad categories of causal factors: ogy, paleopathology, archeology, history, psychology, epidemiology, genetic, infectious, and environmental. -
BIOL 5112/3112: Fundamentals of Genomic Evolutionary Medicine
BIOL 5112/3112: Fundamentals of Genomic Evolutionary Medicine Dr. Sudhir Kumar 602A SERC s.kumar@ temple.edu LECTURE BioLife Science 332 Wednesday: 5:30-8:00 pm OFFICE HOURS By appointment Offered in the Spring semester BIOL 5112 SECTION 001 [26318] (For graduate students) BIOL 3112 SECTION 001 [27340] (For undergraduate students) (Graduates and undergraduate attend the lectures together at the same time in the same room. However, undergraduate students will work in small groups in the semester-long student case study projects. Graduate students will work individually on case-study projects.) Prerequisite: Biology 2112 with a grade of C or better. Course Description: Modern evolutionary theory offers a conceptual framework for understanding human health and disease. In this course we will examine human disease in evolutionary contexts with a focus on modern techniques and genome-scale datasets. We ask: What can evolution teach us about human populations? How can we understand disease from molecular evolutionary perspectives? What are the relative roles of negative and positive selection in disease? How do we apply evolutionary principles in to diagnose diseases and develop better treatments? Students will become familiar with current research through guided case studies. This course focuses on discovery-based learning. Course Learning Objectives 1. Explain key concepts of evolutionary biology and medicine from a genomic perspective 2. Integrate key evolutionary concepts and principles to explain various aspects of human health and disease 3. Develop familiarity with current research relevant to evolutionary and genomic medicine 4. Evaluate how genomics and phylomedicine fit into the broader context of modern healthcare 5. -
An Evolutionary Telescope to Explore and Diagnose the Universe of Disease Mutations
Review Phylomedicine: an evolutionary telescope to explore and diagnose the universe of disease mutations Sudhir Kumar1,2, Joel T. Dudley3,4, Alan Filipski1,2 and Li Liu2 1 School of Life Sciences, Arizona State University, Tempe, AZ 85287-4501, USA 2 Center for Evolutionary Medicine and Informatics, The Biodesign Institute, Arizona State University, Tempe, AZ 85287-5301, USA 3 Division of Systems Medicine, Department of Pediatrics, Stanford University School of Medicine, Stanford, CA 94305, USA 4 Biomedical Informatics Training Program, Stanford University School of Medicine, Stanford, CA 94305, USA Modern technologies have made the sequencing of per- robust picture of the amount and types of variations found sonal genomes routine. They have revealed thousands within and between human individuals and populations. of nonsynonymous (amino acid altering) single nucleo- Any one personal genome contains more than a million tide variants (nSNVs) of protein-coding DNA per ge- variants, the majority of which are single nucleotide var- nome. What do these variants foretell about an iants (SNVs) (Figure 1b). With the complete sequencing of individual’s predisposition to diseases? The experimen- each new genome, the number of novel variants discovered tal technologies required to carry out such evaluations at is decreasing, but the total number of known variants is a genomic scale are not yet available. Fortunately, the growing quickly (Figure 2a). Our knowledge of the number process of natural selection has lent us an almost infinite of disease genes and the total number of known disease- set of tests in nature. During long-term evolution, new associated SNVs has grown with these advances [12]. -
Unbiased Estimate of Synonymous and Non-Synonymous Substitution Rates with Non-Stationary Base Composition
Manuscript submitted as an article for the methods section of MBE bioRxiv preprint doi: https://doi.org/10.1101/124925; this version posted April 6, 2017. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. Unbiased estimate of synonymous and non-synonymous substitution rates with non-stationary base composition Laurent Gu´eguen∗ and Laurent Duret Laboratoire de Biologie et Biom´etrie Evolutive´ CNRS UMR 5558 {Universit´eClaude Bernard Lyon 1 { Universit´ede Lyon 43, bd du 11 novembre 1918,69622 VILLEURBANNE cedex ∗ [email protected] Abstract The measure of synonymous and non-synonymous substitution rates (dS and dN) is useful for assessing selection operating on protein sequences or for investigating mutational processes dN affecting genomes. In particular, the ratio dS is expected to be a good proxy of !, the probability of fixation of non-synonymous mutations relative to that of neutral mutations. Standard methods for estimating dN, dS or ! rely on the assumption that the base composition of sequences is at the equilibrium of the evolutionary process. In many clades, this assumption of stationarity is in fact incorrect, and we show here through simulations and through analyses of empirical data that non-stationarity biases the estimate of dN, dS and !. We show that the bias in the estimate of ! can be fixed by explicitly considering non-stationarity in the modeling of codon evolution, in a maximum likelihood framework. -
Phylomedicine: an Evolutionary Telescope to Explore and Diagnose the Universe of Disease Mutations
TIGS-899; No. of Pages 10 Review Phylomedicine: an evolutionary telescope to explore and diagnose the universe of disease mutations 1,2 3,4 1,2 2 Sudhir Kumar , Joel T. Dudley , Alan Filipski and Li Liu 1 School of Life Sciences, Arizona State University, Tempe, AZ 85287-4501, USA 2 Center for Evolutionary Medicine and Informatics, The Biodesign Institute, Arizona State University, Tempe, AZ 85287-5301, USA 3 Division of Systems Medicine, Department of Pediatrics, Stanford University School of Medicine, Stanford, CA 94305, USA 4 Biomedical Informatics Training Program, Stanford University School of Medicine, Stanford, CA 94305, USA Modern technologies have made the sequencing of per- robust picture of the amount and types of variations found sonal genomes routine. They have revealed thousands within and between human individuals and populations. of nonsynonymous (amino acid altering) single nucleo- Any one personal genome contains more than a million tide variants (nSNVs) of protein-coding DNA per ge- variants, the majority of which are single nucleotide var- nome. What do these variants foretell about an iants (SNVs) (Figure 1b). With the complete sequencing of individual’s predisposition to diseases? The experimen- each new genome, the number of novel variants discovered tal technologies required to carry out such evaluations at is decreasing, but the total number of known variants is a genomic scale are not yet available. Fortunately, the growing quickly (Figure 2a). Our knowledge of the number process of natural selection has lent us an almost infinite of disease genes and the total number of known disease- set of tests in nature. -
The KA /KS Ratio Test for Assessing the Protein
Downloaded from genome.cshlp.org on September 26, 2021 - Published by Cold Spring Harbor Laboratory Press Methods The KA/KS Ratio Test for Assessing the Protein-Coding Potential of Genomic Regions: An Empirical and Simulation Study Anton Nekrutenko, Kateryna D. Makova, and Wen-Hsiung Li1 Department of Ecology and Evolution, University of Chicago, Chicago, Illinois 60637, USA Comparative genomics is a simple, powerful way to increase the accuracy of gene prediction. In this study, we show the utility of a simple test for the identification of protein-coding exons using human/mouse sequence comparisons. The test takes advantage of the fact that in the vast majority of coding regions, synonymous substitutions (KS) occur much more frequently than nonsynonymous ones (KA) and uses the KA/KS ratio as the criterion. We show the following: (1) most of the human and mouse exons are sufficiently long and have a suitable degree of sequence divergence for the test to perform reliably; (2) the test is suited for the identification of long exons and single exon genes, which are difficult to predict by current methods; (3) the test has a false-negative rate, lower than most of current gene prediction methods and a false-positive rate lower than all current methods; (4) the test has been automated and can be used in combination with other existing gene-prediction methods. Although computational gene prediction has made much test), which is described below. Nucleotide substitutions in progress over the last decade, its reliability remains a challeng- protein-coding regions are divided into two classes, ones that ing problem. -
Molecular Phylogeny and Evolution
Molecular Phylogeny and Evolution 10 – 14 February 2020 Juan I. MONTOYA BURGOS Lab of Molecular Phylogeny and Evolution in Vertebrates Title of the course: Molecular Phylogeny and Molecular Evolution Evolutionary relationships among organisms = tree topology A better understanding of molecular evolution improves: First phylogenetic methods did not - topology and branch length make use of models of molecular reconstruction (=phylogenetic tree) evolution (UPGMA, Maximum Parsimony) Better phylogenetic trees improve: - the understanding of evolutionary processes => Models of molecular evolution Lab of Molecular Phylogeny and Evolution in Vertebrates 1 Why should we care about phylogenies? Are you using phylogenetics ? Lab of Molecular Phylogeny and Evolution in Vertebrates Current phylogenetic methods allow: - reconstruction of evolutionary relationships But also the analysis of: Gene/genome duplication Recombination Evolutionary rates Divergence time among lineages Selective pressure Demography Biodiversity Genetic variability Conservation Biogeography Spread of contagious disease Discovery of biomedical compounds Adaptive evolution Biomonitoring Protein-protein co-evolution And more …. Lab of Molecular Phylogeny and Evolution in Vertebrates 2 Phylogenetic analyses: many uses Understanding evolutionary relationships Determining the closest extant relative to tetrapods Amemiya et al., 2013. The African coelacanth genome provides insights into tetrapod evolution. Nature 496. Lab of Molecular Phylogeny and Evolution in Vertebrates Phylogenetic -
Role of Mrna Structure in the Control of Protein Folding Guilhem Faure, Aleksey Y
10898–10911 Nucleic Acids Research, 2016, Vol. 44, No. 22 Published online 27 July 2016 doi: 10.1093/nar/gkw671 Role of mRNA structure in the control of protein folding Guilhem Faure, Aleksey Y. Ogurtsov, Svetlana A. Shabalina and Eugene V. Koonin* National Center for Biotechnology Information, National Library of Medicine, National Institutes of Health, Bethesda, MD 20894, USA Received May 03, 2016; Revised July 12, 2016; Accepted July 14, 2016 ABSTRACT speed and fidelity of translation. Although much attention had focused on the initiation step as a major determinant Specific structures in mRNA modulate translation of translation rate, multiple studies over nearly two decades rate and thus can affect protein folding. Using the have made it clear that elongation also plays an important protein structures from two eukaryotes and three role in the regulation of translation and co-translational prokaryotes, we explore the connections between protein folding (1–3). In particular, it has been shown that the protein compactness, inferred from solvent ac- in some proteins, ␣-helices and -strands are flanked by cessibility, and mRNA structure, inferred from mRNA strong signals in the mRNA sequence (4,5). Different pro- folding energy (G). In both prokaryotes and eukary- tein structures have been reported to correlate with distinct otes, the G value of the most stable 30 nucleotide patterns of synonymous codon usage in the respective mR- segment of the mRNA (Gmin) strongly, positively NAs (6,7). More generally, it has been proposed that dif- correlates with protein solvent accessibility. Thus, ferent protein secondary structures are encoded by mRNA sequences with distinct properties.